肥胖是一个医学问题.
1St Bartholomew's & The Royal London School of Medicine, Queen Mary & Westfield College, UK. P.G.Kopelman@mds.qmw.ac.uk
Nature
|April 15, 2000
概括
肥胖是一个日益严重的全球健康危机,超过营养不良和感染作为疾病的主要原因. 它与糖尿病,心脏病和癌症等严重疾病有关,需要紧急关注.
科学领域:
- 公共卫生 公共卫生
- 流行病学 流行病学
- 代谢障碍 代谢障碍 代谢障碍
背景情况:
- 肥胖是一个重要的全球健康问题,在世界各地越来越普遍.
- 它与严重的健康状况有关,包括糖尿病,冠心病,癌症和睡眠呼吸障碍.
- 使用体重指数 (BMI) 的传统定义并不能完全捕捉健康风险,特别是与腹内脂肪相关的风险.
研究的目的:
- 为了强调全球肥胖流行病的不断升级.
- 为了强调肥胖对健康的多方面的后果,超越了整容方面的担忧.
- 强调需要解决肥胖问题,因为肥胖是一个主要的公共卫生威胁.
主要方法:
- 对目前关于肥胖患病率的流行病学数据的审查.
- 分析肥胖和主要非传染性疾病之间的确立关联.
- 讨论导致肥胖流行病的病因因素.
主要成果:
- 肥胖正在成为全球疾病和死亡的主要原因.
- 肥胖和慢性疾病的发展之间存在着强烈的相关性.
- 诸如遗传倾向,增加对高热量食物的获取和减少体力活动等因素推动了这一流行病.
结论:
- 肥胖是一个复杂的流行病,对全球健康有深远的影响.
- 它需要从个人化品问题转变为广泛的公共卫生挑战.
- 解决肥胖的根本原因对于改善全球福祉至关重要.
相关概念视频
Obesity
1.6K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.6K
Drug Dosing: Obese Patients
372
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
372
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
445
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
445
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
330
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
330
Bulimia Nervosa
1.1K
Bulimia nervosa is a complex and severe eating disorder characterized by a cyclical pattern of binge-and-purge eating pattern. It generally involves an episode of binge eating, followed by compensatory behaviors such as vomiting, excessive exercise, laxative use, or fasting, to prevent weight gain. Despite often maintaining a normal weight, individuals with bulimia are intensely preoccupied with their body image and harbor an overwhelming fear of gaining weight. This can contribute to the...
1.1K
Binge Eating Disorders
832
Binge eating disorder is a significant mental health condition characterized by recurrent episodes of excessive food consumption within a short period, accompanied by a perceived loss of control over eating behavior. Unlike occasional overeating, binge eating disorder is marked by distressing emotions such as guilt, shame, and anxiety following binge episodes. The disorder affects individuals across different ages and backgrounds, with profound implications for physical and psychological...
832


